A long-acting biologic with transmucosal transport properties that stops SARS-CoV-2 virus variants
A pan-SARS-CoV-2-specific soluble ACE2-albumin fusion designed for enhanced plasma half-life and needle-free mucosal delivery. Credit: Sopisa Benjakul, Aina Anthi and ...
